Neuroinflammation in Alzheimer's Disease
|Heneka, Michael T.
Carson, Monica J.
El Khoury, Joseph
Landreth, Gary E.
Feinstein, Douglas L.
Vitorica Ferrández, Francisco Javier
Kummer, Markus P.
|Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular
|Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment but strongly interacts with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to ...
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment but strongly interacts with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on micro- and astroglia and trigger an innate immune response, characterized by the release of inflammatory mediators, which contribute to disease progression and severity. Genome wide analysis suggests that several genes, which increase the risk for sporadic Alzheimer's disease en-code for factors that regulate glial clearance of misfolded proteins and the inflammatory reaction. External factors, including systemic inflammation and obesity are likely to interfere with the immunological processes of the brain and further promote disease progression. This re-view provides an overview on the current knowledge and focuses on the most recent and exciting findings. Modulation of risk factors and intervention with the described immune mechanisms are likely to lead to future preventive or therapeutic strategies for Alzheimer's disease.
|Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L.,...,Kummer, M.P. (2015). Neuroinflammation in Alzheimer's Disease. Lancet Neurology, 14 (4), 388-405. https://doi.org/10.1016/S1474-4422(15)70016-5.